Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 1, 2006, Pages 73-80

  Sundström, Torbjörn ^a   Elgh, Eva ^b   Larsson, Anne ^c   Näsman, Birgitta ^b   Nyberg, Lars ^c   Riklund, Katrine Å ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

99mTc HMPAO; Alzheimer's disease; Memory provocation; rCBF SPECT; Regional cerebral blood flow

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MEMORY; MENTAL TASK; NEUROIMAGING; PARIETAL LOBE; PROVOCATION TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS;

ADULT; AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; EVOKED POTENTIALS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MEMORY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 28944437524     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1874-0     Document Type: Article

References (61)

1. Backman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001;124:96-102
2. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001;58:853-8
3. Grober E, Lipton RB, Hall C, Crystal H. Memory impairment on free and cued selective reminding predicts dementia. Neurology 2000;54:827-32
4. Citron M. Alzheimer's disease: treatments in discovery and development. Nat Neurosci Suppl 2002;5:1055-7
5. Alzheimer A. Über eine eigenartige Erkrangung der Hirnrinde. Allg Z Psychiatr 1907;64:146-8
6. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S4-9
7. Cummings JL, Benson DF. Dementia: a clinical approach. Boston: Butterworth-Heinemann; 1992
8. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S10-5
9. Waldemar G, Hogh P, Paulson OB. Functional brain imaging with single-photon emission computed tomography in the diagnosis of Alzheimer's disease. Int Psychogeriatr 1997;9 Suppl 1:223-7; discussion 247-52
10. Lee BC, Mintun M, Buckner RL, Morris JC. Imaging of Alzheimer's disease. J Neuroimaging 2003;13:199-214
11. 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983;40: 711-4
12. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-87
13. Lee AC, Rahman S, Hodges JR, Sahakian BJ, Graham KS. Associative and recognition memory for novel objects in dementia: implications for diagnosis. Eur J Neurosci 2003;18:1660-70
14. Hoffmann J, Twiesselmann C, Kummer MP, Romagnoli P, Herzog V. A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation. Eur J Cell Biol 2000;79:905-14
15. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 1996;165:3-12
16. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-19
17. Wang Y, Klunk WE, Debnath ML, Huang GF, Holt DP, Shao L, et al. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease. J Mol Neurosci 2004;24:55-62
18. 99mTc-HMPAO SPET: developing diagnostics in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2002;29:1140-8
19. Rombouts SA, Barkhof F, Veltman DJ, Machielsen WC, Witter MP, Bierlaagh MA, et al. Functional MR imaging in Alzheimer's disease during memory encoding. Am J Neuroradiol 2000;21:1869-75
20. Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, et al. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. Clin Neurophysiol 2005;116:364-75
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
22. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
24. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72
25. Meikle SR, Hutton BF, Bailey DL. A transmission-dependent method for scatter correction in SPECT. J Nucl Med 1994;35:360-7
26. Van Laere KJ, Versijpt J, Koole M, Vandenberghe S, Lahorte P, Lemahieu I, et al. Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design. NeuroImage 2002;16:200-16
27. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imag 1994;13:601-9
28. 99mTc-labelled radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2002;29:BP36-42
29. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 2002;15:870-8
30. 99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988;8:S13-22
31. Buschke H. Cued recall in amnesia. J Clin Neuropsychol 1984;6:433-40
32. Meyers JE, Meyers KR. Rey Complex Figure Test under four different administration procedures. Clin Neuropsychol 1995:63-67 JN: Clinical-Neu
33. Kluger A, Ferris SH, Golomb J, Mittelman MS, Reisberg B. Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol 1999;12:168-79
34. Nilsson L-G, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, et al. The Betula prospective cohort study: memory, health, and aging. Aging Neuropsychol Cogn 1997:1-32
35. Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press; 1991
36. Wechsler D. Wechsler Adult Intelligence Scale-Revised (WAIS-R). New York:: The Psychological Corporation; 1981
37. Kaplan E, Fein D, Morris R, Delis D. WAIS-R as a neuro psychological instrument. New York: The Psychological Corporation; 1991
38. Reitan RM. Trail Making Test: manual for administration and scoring. Tucson, AZ: Reitan Neuropsychology Laboratory; 1992
39. Nordberg A. Toward an early diagnosis and treatment of Alzheimer's disease. Int Psychogeriatr 2003;15:223-37
40. 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging 2003;30:1473-80
41. Kaneko K, Kuwabara Y, Sasaki M, Ogomori K, Ichimiya A, Koga H, et al. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT. Clin Nucl Med 2004;29:362-6
42. Elgh E, Larsson A, Eriksson S, Nyberg L. Altered prefrontal brain activity in persons at risk for Alzheimer's disease: an fMRI study. Int Psychogeriatr 2003;15:121-33
43. m-HMPAO brain SPECT in Alzheimer's disease. Nucl Med Commun 2000;21:763-8
44. Beversdorf D, Metzger S, Nelson D, Alonso R, Right J. Single-word auditory stimulation and regional cerebral blood flow as studied by SPECT. Psychiatry Res 1995;61:181-9
45. Cardebat D, Demonet JF, Puel M, Agniel A, Viallard G, Celsis P. Brain correlates of memory processes in patients with dementia of Alzheimer's type: a SPECT activation study. J Cereb Blood Flow Metab 1998;18:457-62
46. Tonini G, Shanks MF, Venneri A. Short-term longitudinal evaluation of cerebral blood flow in mild Alzheimer's disease. Neurol Sci 2003;24:24-30
47. Garrido GE, Furuie SS, Buchpiguel CA, Bottino CM, Almeida OP, Cid CG, et al. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study. J Neurol Neurosurg Psychiatry 2002;73:508-16
48. Zheng XM. Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT? J Nucl Med Technol 2002;30:118-22
49. Backman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 1999;52:1861-70
50. Ryding E. SPECT measurements of brain function in dementia; a review. Acta Neurol Scand Suppl 1996;168:54-8
51. Jagust WJ. Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology. Ann NY Acad Sci 1996;777:30-6
52. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-9
53. Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 2001;7:631-9
54. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000;55:1847-53
55. Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, et al. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988;10:576-96
56. Lafleche G, Albert M. Executive function deficits in mild Alzheimer's disease. Neuropsychology 1995;9:313-20
57. Kato T, Knopman D, Liu H. Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology 2001;57:812-6
58. Gilleard CJ. Education and Alzheimer's disease: a review of recent international epidemiological studies. Aging Ment Health 1997;1:33-6
59. De Jager CA, Hogervorst E, Combrinck M, Budge MM. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med 2003;33:1039-50
60. Lovden M, Ronnlund M, Wahlin A, Backman L, Nyberg L, Nilsson LG. The extent of stability and change in episodic and semantic memory in old age: demographic predictors of level and change. J Gerontol B Psychol Sci Soc Sci 2004;59:P130-4
61. Stern Y, Alexander GE, Prohovnik I, Mayeux R. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992;32:371-5